Page last updated: 2024-08-21

fluorobenzenes and Myocardial Ischemia

fluorobenzenes has been researched along with Myocardial Ischemia in 20 studies

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	12 (60.00)	29.6817
2010's	8 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beanlands, RSB; deKemp, RA; Garrard, L; Hadizad, T; Mielniczuk, LM; Orlandi, C; Robinson, S; Walter, O; Zelt, JGE	1
Chen, L; Chen, Z; Fan, L; Fang, J; Ke, D	1
Chen, C; Dai, R; Lin, R; Su, Z; Wu, B; Wu, H	1
Böhm, M; Cleland, JG; Gullestad, L; Jhund, PS; Kjekshus, J; McMurray, JJ; Perez, AC; Pocock, SJ; Rogers, JK; van Veldhuisen, DJ; Wedel, H; Wikstrand, J	1
Ansimova, OM; Chalyk, NE; Dovgalevskiĭ, PIa; Il'in, AA; Klochkov, VA; Petyaev, I	1
Chang, SA; Kim, DH; Kim, HK; Kim, YJ; Oh, BH; Park, YB; Sohn, DW	1
Genest, J; Glynn, RJ; Hsia, J; MacFadyen, JG; Mora, S; Ridker, PM	1
Goettsch, WG; González-Pérez, A; Herings, RM; Johansson, S; McAfee, AT; Ming, EE; Rodríguez, LA; Wallander, MA	1
Ge, J; Hu, X; Huang, Z; Jia, J; Sun, A; Xie, X; Yao, R	1
Bulhak, AA; Gonon, AT; Gourine, AV; Pernow, J; Sjöquist, PO; Valen, G	1
Balakhonova, TV; Ezhov, MV; Masenko, VP; Naumov, VG; Pogorelova, OA; Samoĭlenko, EIu; Sergienko, IV; Sumarokov, AB; Tkachev, GA	1
Ayadhi, T; Böhm, M; Link, A; Nickenig, G	1
Bulhak, A; Hedin, U; Pernow, J; Roy, J; Sjöquist, PO	1
Apetrei, E; Barrios, V; Böhm, M; Cleland, JG; Cornel, JH; Dunselman, P; Fonseca, C; Goudev, A; Grande, P; Gullestad, L; Hjalmarson, A; Hradec, J; Jánosi, A; Kamenský, G; Kjekshus, J; Komajda, M; Korewicki, J; Kuusi, T; Mach, F; Mareev, V; McMurray, JJ; Ranjith, N; Schaufelberger, M; van Veldhuisen, DJ; Vanhaecke, J; Waagstein, F; Wedel, H; Wikstrand, J	1
Masoudi, FA	1
Belenkov, IuN; Ezhov, MV; Gabrusenko, SA; Kukharchuk, VV; Masenko, VP; Semenova, AE; Sergienko, IV	1
Belenkov, IuN; Gabrusenko, SA; Kukharchuk, VV; Masenko, VP; Semenova, AE; Sergienko, IV	1
Maslov, LN	1
Ichihara, K; Itagaki, M; Kano, S; Satoh, K; Takaguri, A	1
Angermann, CE; Nitschmann, S	1

Reviews

2 review(s) available for fluorobenzenes and Myocardial Ischemia

Article	Year
Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUP Circulation, 2010, Mar-09, Volume: 121, Issue:9 Topics: Aged; C-Reactive Protein; Cholesterol, LDL; Comorbidity; Double-Blind Method; Dyslipidemias; Early Termination of Clinical Trials; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscular Diseases; Myocardial Ischemia; Proportional Hazards Models; Pyrimidines; Risk; Risk Factors; Rosuvastatin Calcium; Sex Factors; Stroke; Sulfonamides; Treatment Outcome	2010
[Coronary perfusion, necrosis area, pumping function of the myocardium, and cardiac electrical stability following revascularisation of infarction-affected myocardium]. Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery, 2007, Volume: 13, Issue:4 Topics: Aged; Anticholesteremic Agents; C-Reactive Protein; Female; Fluorobenzenes; Heart Rate; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Revascularization; Necrosis; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Vascular Endothelial Growth Factor A; Vasodilation	2007

Article

Year

Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUP

Circulation, 2010, Mar-09, Volume: 121, Issue:9

Topics: Aged; C-Reactive Protein; Cholesterol, LDL; Comorbidity; Double-Blind Method; Dyslipidemias; Early Termination of Clinical Trials; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscular Diseases; Myocardial Ischemia; Proportional Hazards Models; Pyrimidines; Risk; Risk Factors; Rosuvastatin Calcium; Sex Factors; Stroke; Sulfonamides; Treatment Outcome

2010

[Coronary perfusion, necrosis area, pumping function of the myocardium, and cardiac electrical stability following revascularisation of infarction-affected myocardium].

Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery, 2007, Volume: 13, Issue:4

Topics: Aged; Anticholesteremic Agents; C-Reactive Protein; Female; Fluorobenzenes; Heart Rate; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Revascularization; Necrosis; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Vascular Endothelial Growth Factor A; Vasodilation

2007

Trials

7 trial(s) available for fluorobenzenes and Myocardial Ischemia

Article	Year
Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure). JACC. Heart failure, 2014, Volume: 2, Issue:3 Topics: Aged; Chronic Disease; Epidemiologic Methods; Female; Fluorobenzenes; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Myocardial Ischemia; Pyrimidines; Recurrence; Rosuvastatin Calcium; Sulfonamides	2014
Persistent regional diastolic dysfunction after myocardial ischemia and the effect of statin treatment: assessment with two-dimensional radial strain rate. Echocardiography (Mount Kisco, N.Y.), 2010, Volume: 27, Issue:3 Topics: Angina Pectoris, Variant; Atorvastatin; Diastole; Exercise Test; Female; Fluorobenzenes; Heart; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Ischemia; Pyrimidines; Pyrroles; Reference Standards; Rosuvastatin Calcium; Sulfonamides; Ultrasonography; Ventricular Dysfunction, Left	2010
Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUP Circulation, 2010, Mar-09, Volume: 121, Issue:9 Topics: Aged; C-Reactive Protein; Cholesterol, LDL; Comorbidity; Double-Blind Method; Dyslipidemias; Early Termination of Clinical Trials; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscular Diseases; Myocardial Ischemia; Proportional Hazards Models; Pyrimidines; Risk; Risk Factors; Rosuvastatin Calcium; Sex Factors; Stroke; Sulfonamides; Treatment Outcome	2010
Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome. European heart journal, 2006, Volume: 27, Issue:24 Topics: Aged; C-Reactive Protein; Coronary Artery Disease; Cytokines; Double-Blind Method; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunologic Factors; Lipids; Male; Middle Aged; Monocytes; Myocardial Ischemia; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; T-Lymphocytes	2006
Rosuvastatin in older patients with systolic heart failure. The New England journal of medicine, 2007, Nov-29, Volume: 357, Issue:22 Topics: Aged; Cardiovascular Diseases; Female; Fluorobenzenes; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Ischemia; Proportional Hazards Models; Pyrimidines; Rosuvastatin Calcium; Single-Blind Method; Sulfonamides; Systole; Treatment Outcome	2007
[Effect of statin therapy on dynamics of vascular endothelial growth factor and fibroblast growth factor in patients with ischemic heart disease]. Kardiologiia, 2007, Volume: 47, Issue:8 Topics: Aged; Fibroblast Growth Factors; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Middle Aged; Myocardial Ischemia; Neovascularization, Physiologic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Vascular Endothelial Growth Factor A	2007
[Effect of rosuvastatin therapy and myocardial revascularization on angiogenesis in coronary artery disease patients]. Kardiologiia, 2007, Volume: 47, Issue:11 Topics: Anticholesteremic Agents; Cholesterol; Female; Fluorobenzenes; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Neovascularization, Pathologic; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Rosuvastatin Calcium; Sulfonamides; Transforming Growth Factor beta1; Triglycerides; Vascular Endothelial Growth Factor A	2007

Other Studies

12 other study(ies) available for fluorobenzenes and Myocardial Ischemia

Article	Year
PET imaging of sympathetic innervation with [ Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019, Volume: 26, Issue:6 Topics: Aged; Cardiomyopathies; Ephedrine; Fluorobenzenes; Guanidines; Humans; Male; Myocardial Ischemia; Positron Emission Tomography Computed Tomography; Risk; ST Elevation Myocardial Infarction; Sympathetic Nervous System	2019
Regulatory T cells contribute to rosuvastatin-induced cardioprotection against ischemia-reperfusion injury. Coronary artery disease, 2013, Volume: 24, Issue:4 Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Fluorobenzenes; Forkhead Transcription Factors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mevalonic Acid; Myocardial Ischemia; Myocardial Reperfusion Injury; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides; T-Lymphocytes, Regulatory; Troponin I	2013
Short-time pretreatment of rosuvastatin attenuates myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein expression. International journal of cardiology, 2013, Oct-12, Volume: 168, Issue:5 Topics: Animals; Biomarkers; Fluorobenzenes; HMGB1 Protein; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Malondialdehyde; Myocardial Ischemia; Oxidative Stress; Premedication; Pyrimidines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rosuvastatin Calcium; Sulfonamides; Superoxide Dismutase	2013
[Significance of determination of lipid-oxidizing catalytic antibodies in patients with ischemic heart diseases]. Klinicheskaia laboratornaia diagnostika, 2009, Issue:8 Topics: Aged; Antibodies, Catalytic; Antigens, Bacterial; Antioxidants; Carotenoids; Chlamydophila pneumoniae; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Lipid Peroxidation; Lycopene; Male; Malondialdehyde; Middle Aged; Myocardial Ischemia; Oxidation-Reduction; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2009
Characteristics and drug utilization patterns of new users of rosuvastatin and other statins in four countries. Minerva cardioangiologica, 2010, Volume: 58, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Canada; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Medical Records Systems, Computerized; Middle Aged; Myocardial Ischemia; Netherlands; Pharmacoepidemiology; Prospective Studies; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; United Kingdom; United States	2010
Rosuvastatin changes cytokine expressions in ischemic territory and preserves heart function after acute myocardial infarction in rats. Journal of cardiovascular pharmacology and therapeutics, 2013, Volume: 18, Issue:2 Topics: Animals; Cytokines; Fluorobenzenes; Gene Expression Regulation; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Myocardial Ischemia; Pyrimidines; Random Allocation; Rats; Rats, Sprague-Dawley; Rosuvastatin Calcium; Sulfonamides; Ventricular Remodeling	2013
Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level. Acta physiologica Scandinavica, 2005, Volume: 183, Issue:2 Topics: Administration, Oral; Animals; Blood Pressure; Cholesterol; Female; Fluorobenzenes; Heart; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Neutrophil Infiltration; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peroxidase; Pravastatin; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Swine	2005
[Effect of therapy with rosuvastatin on lipid spectrum, factors of inflammation and endothelial function in patients with ischemic heart disease]. Kardiologiia, 2006, Volume: 46, Issue:5 Topics: Biomarkers; Brachial Artery; C-Reactive Protein; Endothelium, Vascular; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lipids; Male; Middle Aged; Myocardial Ischemia; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Ultrasonography, Doppler; Vasodilation	2006
Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation. American journal of physiology. Heart and circulatory physiology, 2007, Volume: 292, Issue:6 Topics: Animals; Cardiovascular Agents; Cell Membrane; Cytosol; Disease Models, Animal; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Polyisoprenyl Phosphates; Protein Transport; Pyrimidines; Rats; Rats, Sprague-Dawley; rhoA GTP-Binding Protein; Rosuvastatin Calcium; Sulfonamides	2007
Statins for ischemic systolic heart failure. The New England journal of medicine, 2007, Nov-29, Volume: 357, Issue:22 Topics: Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Ischemia; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Systole; Treatment Failure	2007
Effects of rosuvastatin and pitavastatin on ischemia-induced myocardial stunning in dogs. Journal of pharmacological sciences, 2008, Volume: 106, Issue:4 Topics: Administration, Oral; Animals; Cell Line; Cell Survival; Cholesterol; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Energy Metabolism; Female; Fluorobenzenes; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscle, Skeletal; Myocardial Contraction; Myocardial Ischemia; Myocardial Stunning; Myocardium; Pyrimidines; Quinolines; Rats; Rosuvastatin Calcium; Sulfonamides; Time Factors	2008
[Statin therapy for systolic heart failure. The CORONA trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)]. Der Internist, 2008, Volume: 49, Issue:7 Topics: Aged; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Female; Fluorobenzenes; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Ischemia; Proportional Hazards Models; Pyrimidines; Rosuvastatin Calcium; Single-Blind Method; Sulfonamides; Systole; Treatment Outcome	2008